phosphatidylcholines has been researched along with sumatriptan in 3 studies
Studies (phosphatidylcholines) | Trials (phosphatidylcholines) | Recent Studies (post-2010) (phosphatidylcholines) | Studies (sumatriptan) | Trials (sumatriptan) | Recent Studies (post-2010) (sumatriptan) |
---|---|---|---|---|---|
32,204 | 443 | 5,593 | 2,405 | 461 | 480 |
Protein | Taxonomy | phosphatidylcholines (IC50) | sumatriptan (IC50) |
---|---|---|---|
5-hydroxytryptamine receptor 3E | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 3B | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 1A | Homo sapiens (human) | 0.4497 | |
Carboxypeptidase M | Homo sapiens (human) | 0.02 | |
Alpha-1B adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 1A | Rattus norvegicus (Norway rat) | 0.722 | |
Alpha-1D adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 1D | Homo sapiens (human) | 0.3091 | |
5-hydroxytryptamine receptor 1B | Homo sapiens (human) | 0.0131 | |
5-hydroxytryptamine receptor 2A | Homo sapiens (human) | 7.9433 | |
5-hydroxytryptamine receptor 2C | Homo sapiens (human) | 3.9753 | |
5-hydroxytryptamine receptor 1B | Rattus norvegicus (Norway rat) | 0.804 | |
5-hydroxytryptamine receptor 1D | Rattus norvegicus (Norway rat) | 0.061 | |
5-hydroxytryptamine receptor 1E | Homo sapiens (human) | 5.5 | |
Alpha-1A adrenergic receptor | Rattus norvegicus (Norway rat) | 0.64 | |
5-hydroxytryptamine receptor 3A | Homo sapiens (human) | 0.0078 | |
5-hydroxytryptamine receptor 5A | Homo sapiens (human) | 0.5012 | |
5-hydroxytryptamine receptor 1D | Sus scrofa (pig) | 0.02 | |
5-hydroxytryptamine receptor 1A | Mus musculus (house mouse) | 0.45 | |
5-hydroxytryptamine receptor 3D | Homo sapiens (human) | 0.0073 | |
5-hydroxytryptamine receptor 3C | Homo sapiens (human) | 0.0073 | |
Multidrug and toxin extrusion protein 1 | Homo sapiens (human) | 6.7 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
González-Rodríguez, ML; Rabasco, AM; Villasmil-Sánchez, S | 1 |
Pickholz, M; Wood, I | 2 |
3 other study(ies) available for phosphatidylcholines and sumatriptan
Article | Year |
---|---|
Thermal and 31P-NMR studies to elucidate sumatriptan succinate entrapment behavior in phosphatidylcholine/cholesterol liposomes. Comparative 31P-NMR analysis on negatively and positively-charged liposomes.
Topics: Amines; Calorimetry, Differential Scanning; Cholesterol; Lipid Bilayers; Liposomes; Magnetic Resonance Spectroscopy; Organophosphates; Phosphatidylcholines; Sumatriptan | 2013 |
Concentration effects of sumatriptan on the properties of model membranes by molecular dynamics simulations.
Topics: Cell Membrane; Dose-Response Relationship, Drug; Lipid Bilayers; Molecular Dynamics Simulation; Phosphatidylcholines; Sumatriptan | 2013 |
Triptan partition in model membranes.
Topics: Drug Stability; Hydrogen Bonding; Lipid Bilayers; Molecular Dynamics Simulation; Molecular Structure; Phosphatidylcholines; Piperidines; Protons; Solubility; Structure-Activity Relationship; Sumatriptan; Tryptamines; Water | 2014 |